rethinkTHC Search
Menu
Study breakdown

CBT with Motivational Enhancement Is the Best-Supported Psychotherapy for Cannabis Use Disorder

Meta AnalysisStrong evidence
The takeaway

A meta-analysis of 22 trials found that cognitive-behavioral therapy combined with motivational enhancement (MET-CBT) significantly increased cannabis abstinence, with point abstinence odds 18 times higher than inactive treatment.

Addiction therapists, CUD treatment programs, clinical psychologists, individuals seeking CUD treatment

What the researchers found

Across 22 RCTs with 3,304 participants, MET-CBT significantly increased point abstinence (OR=18.27) and continuous abstinence (OR=2.72) compared to inactive/non-specific comparators. Dialectical behavioral/acceptance and commitment therapy also increased point abstinence (OR=4.34). Adding contingency management to MET-CBT showed trends toward benefit but was not statistically significant. MET-CBT reduced treatment completion (OR=0.53), suggesting its demands may lead to dropout. No adverse events were reported across any studies.

Why it matters

With no approved medications for CUD, psychosocial interventions are the primary treatment option. This meta-analysis identifies MET-CBT as the most evidence-supported approach while highlighting an important tension: the most effective therapy also had the highest dropout rate.

The numbers in context

22 RCTs; 3,304 participants; MET-CBT point abstinence OR=18.27 (95% CI: 9.00-37.07); continuous abstinence OR=2.72 (1.20-6.19); treatment completion OR=0.53 (0.35-0.85); DBT/ACT point abstinence OR=4.34 (1.74-10.80); no adverse events reported

How the study worked

Systematic review and pairwise meta-analysis of 22 RCTs (3,304 participants) of psychosocial interventions for CUD lasting more than 4 sessions. Searched MEDLINE, PsycINFO, and Cochrane CENTRAL through June 2024. Assessed using Risk of Bias 2. Registered with PROSPERO.

What this study cannot tell us

Low to very low certainty evidence overall. Only one study had low risk of bias. Small number of studies for each comparison. Point abstinence (negative urine at end of treatment) may overestimate sustained abstinence. No studies reported withdrawal intensity.

How to read the evidence

Strong: systematic review with meta-analysis of RCTs, PROSPERO-registered, though overall evidence certainty was low to very low.

When this study was published

2025 publication with literature search through June 2024

The bigger picture

The very high point abstinence OR for MET-CBT is encouraging, but the lower treatment completion rate means the real-world effectiveness may be more modest than efficacy data suggest. Finding ways to retain patients in MET-CBT could substantially improve CUD outcomes.

Questions still open

  • How can MET-CBT retention be improved without reducing effectiveness?
  • Would digital or app-based CBT delivery improve completion rates?

Read the original research

Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta-analysis.

Addiction (Abingdon, England), 120(11), 2181-2201

Citation

Halicka, Monika; Parkhouse, Thomas L; Webster, Katie; Spiga, Francesca; Hines, Lindsey A; Freeman, Tom P; Sanghera, Sabina; Dawson, Sarah; Paterson, Craig; Savović, Jelena; Higgins, Julian P T; Caldwell, Deborah M. (2025). Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta-analysis.. Addiction (Abingdon, England), 120(11), 2181-2201. https://doi.org/10.1111/add.70084

Explore the wider topic